The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
reported to
the Securities and Exchange Commission (SEC)
by insider Southwell David P since year 2005.
The trader's CIK number is 1251553.
At the time of this reporting, Southwell David P is the Director of Rocket Pharmaceuticals, Inc. .
(stock ticker symbol RCKT).
See this page for all insider trading activities at Rocket Pharmaceuticals, Inc. .
| Trade Date | Symbol | Company Name (Issuer) | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|---|
| 2018-04-02 | RCKT | Rocket Pharmaceuticals, Inc. | Option Ex | 21,875 | .00 | 0 |
| 2017-01-06 | ITEK | Rocket Pharmaceuticals, Inc. | Buy | 60,000 | 1.75 | 105,000 |
| 2015-07-06 | PTCT | Ptc Therapeutics, Inc. | Option Ex | 15,000 | 10.85 | 162,750 |
| 2015-07-06 | PTCT | Ptc Therapeutics, Inc. | Sale | 23,604 | 47.86 | 1,129,687 |
| 2015-03-23 | PTCT | Ptc Therapeutics, Inc. | Sale | 2,317 | 69.45 | 160,915 |
| 2014-03-21 | PTCT | Ptc Therapeutics, Inc. | Sale | 2,317 | 30.95 | 71,699 |
| 2010-12-06 | TCRD | Thl Credit, Inc. | Buy | 12,100 | 12.99 | 157,142 |
| 2010-11-24 | TCRD | Thl Credit, Inc. | Buy | 200 | 12.84 | 2,568 |
| 2010-11-23 | TCRD | Thl Credit, Inc. | Buy | 100 | 12.83 | 1,283 |
| 2010-11-22 | TCRD | Thl Credit, Inc. | Buy | 101 | 12.83 | 1,295 |
| 2010-11-18 | TCRD | Thl Credit, Inc. | Buy | 11,400 | 12.83 | 146,262 |
| 2010-11-19 | TCRD | Thl Credit, Inc. | Buy | 499 | 12.84 | 6,404 |
| 2010-11-16 | TCRD | Thl Credit, Inc. | Buy | 8,622 | 12.84 | 110,706 |
| 2010-11-17 | TCRD | Thl Credit, Inc. | Buy | 5,478 | 12.82 | 70,227 |
| 2010-06-01 | HGSI | Human Genome Sciences Inc | Option Ex | 17,653 | 4.54 | 80,232 |
| 2009-05-20 | BSMD | Biosphere Medical Inc | Option Ex | 2,000 | .81 | 1,626 |
| 2009-03-13 | HGSI | Human Genome Sciences Inc | Buy | 73,000 | .72 | 52,341 |
| 2007-09-10 | SEPR | Sepracor Inc /de/ | Sale | 8,300 | 27.99 | 232,325 |
| 2007-09-10 | SEPR | Sepracor Inc /de/ | Sale | 21,189 | 27.60 | 584,816 |
| 2007-09-10 | SEPR | Sepracor Inc /de/ | Option Ex | 50,000 | 6.24 | 312,000 |
| 2007-09-10 | SEPR | Sepracor Inc /de/ | Sale | 20,511 | 27.30 | 559,929 |
| 2007-09-04 | SEPR | Sepracor Inc /de/ | Option Ex | 50,000 | 6.24 | 312,000 |
| 2007-09-04 | SEPR | Sepracor Inc /de/ | Sale | 21,399 | 29.00 | 620,464 |
| 2007-09-04 | SEPR | Sepracor Inc /de/ | Sale | 16,281 | 29.29 | 476,903 |
| 2007-09-04 | SEPR | Sepracor Inc /de/ | Sale | 17,096 | 29.35 | 501,767 |
| 2007-07-17 | SEPR | Sepracor Inc /de/ | Option Ex | 2,000 | 19.31 | 38,620 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Southwell David P (Director of Rocket Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.